Physician profile
Avinainder Singh
NPI 1811492408
$4,043.72
in general payments reported to CMS, 2019-2025
11 companies · $3,123 in 2025
The $3,123 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $205 · 2022: $218 · 2023: $116 · 2024: $380 · 2025: $3,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,377 · Travel and Lodging: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,376.88 |
| Travel and Lodging | $1,243.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,936.65 | 2025 | Optis |
| Amgen INC. | $580.42 | 2021-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $381.58 | 2025 | General - Vascular Access, Rotapro |
| Stryker Corporation | $365.39 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Recor Medical INC | $268.83 | 2024 | Paradise Renal Denervation System |
| Abiomed | $216.65 | 2025 | |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Heartflow, INC. | $91.87 | 2024 | |
| Shockwave Medical, INC | $25.19 | 2025 | |
| Asahi Intecc USA, INC. | $18.25 | 2025 | Asahi Coronary Wires |
| Teleflex LLC | $15.89 | 2025 | Chocolate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinainder Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.